{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-057836","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.494995+00:00","generated_at":"2026-05-19T16:44:03.470472+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Marker Therapeutics stockholders elect directors, approve say-on-pay, ratify auditor at 2025 annual meeting","bullets":["Four director nominees elected: Eansor (4.1M for), Elms (4.1M), Knobil (4.1M), Vera (4.1M); broker non-votes 2.8M.","Advisory vote on named executive officer compensation passed: 4.45M for, 343K against, 13.9K abstain.","Ratification of Marcum LLP as independent auditor for FY2025: 7.49M for, 80.8K against, 53.9K abstain.","Total shares outstanding 11.3M; 67.43% quorum (7.63M shares present or proxy)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-057836","json":"https://secwatch.observer/filing/0001104659-25-057836.json","markdown":"https://secwatch.observer/filing/0001104659-25-057836.md","text":"https://secwatch.observer/filing/0001104659-25-057836.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/0001104659-25-057836-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465925057836/tm2517533d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T16:44:03.470472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}